Lv11
40 积分 2021-09-03 加入
Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2– Advanced Breast Cancer
3天前
已完结
Imaging the hallmarks of cancer
29天前
已完结
Therapeutic advances in HR+/HER2- advanced breast cancer after failure of CDK4/6 inhibitor therapy
29天前
已完结
From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2– breast cancer
29天前
已完结
Charting intratumor heterogeneity from bench to bedside
1个月前
已完结
The next generation of antibody–drug conjugates
1个月前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
1个月前
已完结
Sex differences in immune responses to viruses, bacteria and vaccines
2个月前
已完结
Evolutionary characterization of lung cancer metastasis
2个月前
已完结
Beyond one gene, one target: Next-generation precision oncology
2个月前
已完结
皖公网安备34019202002308
